Evans & PartnersSmall Cap Healthcare Conference ASX:NYR16 September 2026Authorised by Mr. John Moore, Non-Executive Chair, on behalf of the BoardBuilding the Future ofTRPC-based TherapiesImportant Notice and...
Investor Presentation- Evans&Partners Small Cap Healthcare
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Nyrada
- Change in substantial holding - M Azzi
- Cleansing Statement
- Application for quotation of securities - NYR
- Xolatryp Demonstrates Cardioprotection in Preclinical Study
- Nyrada Full Year Results FY2026
Later from Nyrada
- Trading Halt
- Nyrada Successfully Raises AU$12.0 Million Via Placement
- Cap Raise Deck-Building the Future of TRPC-based Therapies
- Proposed issue of securities - NYR
- Nyrada US Patent for Xolatryp Granted
Follow Nyrada into a list and get an email when it puts out news.
Follow Nyrada